Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval
Gilead’s Covid-19 Remdesivir Drug Scores FDA Approval; Shares Surge
FDA Grants Full Approval to Remdesivir for Covid-19
NFLX Stock Price Tumbles After Missing on EPS and Subscriber Growth Estimates
Lilly hires external adviser for Covid-19 drug plant problems
U.S. FDA meeting on Covid-19 vaccines to discuss criteria for emergency nod
Moderna CEO expects Covid-19 vaccine interim results in November – WSJ
Pfizer: The Pace of COVID-19 Vaccine Development Is Remarkable, Says Analyst
Fluidigm Soars 16% As Covid-19 Saliva Test Selected In US; Analyst Sees 78% Upside
Eli Lilly To Snap Up Disarm In $135M Deal; Street Stays Bullish
Halted Trials Raise New Safety Questions About 'Rushed' COVID-19 Vaccines
US Close – Stocks bounce back on sales and sentiment data, Oil choppy on Libya concerns, Gold remains stuck
Pfizer Plans To Apply For FDA's Emergency-Use Approval During Third Week Of November, CEO Says
COVID-19 tests prop up Roche as US biosimilars bite in Q3
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
BioNTech: COVID-19 Vaccine Submissions Initiated, But This Analyst Still Says Hold Off
Regeneron Scores FDA Nod For Ebola Treatment
Spain First EU Member To Top 900k COVID-19 Cases; France Revives 'Health Emergency' Order, Imposes Curfews: Live Update
France Imposes COVID-19 'Health Emergency'; Macron Expected To Announce Curfew: Live Update
UK's Johnson Mulls "Circuit-Breaker" Lockdown, France To Adopt Hot-Spot Curfews As European Outbreaks Worsen: Live Updates
Eli Lilly pauses trial of Covid-19 antibody drug over safety concern
Operation Warp Speed Boss Projects Covid-19 Vaccine EUA by Thanksgiving
Abbott wins U.S. emergency use authorization for new Covid-19 antibody test
3 COVID-19 Antibody Stocks That Are Leading the Race
Eli Lilly In Gates Foundation Supply Deal For Covid-19 Antibodies
Eli Lily: Intriguing COVID-19 Story, but Questions Remain
GenMark Pops 13% On Very Strong 3Q, FDA Emergency Clearance
Regeneron joins Lilly in seeking emergency OK for COVID-19 antibody
Is Gilead Stock a Buy Right Now? This Is What You Need to Know
Regeneron: Emergency Use Authorization for REGN-COV2 Is Imminent, Says Analyst